Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1992 1
1994 1
2009 1
2010 4
2011 7
2012 5
2013 10
2014 3
2015 1
2016 4
2017 1
2019 2
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Use of complementary and alternative medicine and low quality of life associate with the need for psychological and psychotherapeutic interventions in inflammatory bowel disease.
Kutschera M, Waldhör T, Gröchenig HP, Haas T, Wenzl H, Steiner P, Koch R, Feichtenschlager T, Eckhardt G, Mayer A, Kirchgatterer A, Ludwiczek O, Platzer R, Papay P, Gartner J, Fuchssteiner H, Peters PG, Reicht G, Moser G, Dejaco C, Vogelsang H, Primas C, Novacek G, Miehsler W; Austrian IBD Study Group. Kutschera M, et al. Among authors: papay p. United European Gastroenterol J. 2021 Feb;9(1):72-81. doi: 10.1177/2050640620946874. Epub 2021 Feb 18. United European Gastroenterol J. 2021. PMID: 32723070 Free PMC article.
Prevalence and indicators of use of complementary and alternative medicine in Austrian patients with inflammatory bowel disease.
Gröchenig HP, Waldhör T, Haas T, Wenzl H, Steiner P, Koch R, Feichtenschlager T, Eckhardt G, Mayer A, Kirchgatterer A, Ludwiczek O, Platzer R, Papay P, Gartner J, Fuchssteiner H, Miehsler W, Peters PG, Reicht G, Kutschera M, Dejaco C, Vogelsang H, Novacek G; Austrian IBD Study Group (ATISG). Gröchenig HP, et al. Among authors: papay p. Eur J Gastroenterol Hepatol. 2019 Oct;31(10):1211-1219. doi: 10.1097/MEG.0000000000001533. Eur J Gastroenterol Hepatol. 2019. PMID: 31498280
Diagnostic delay in patients with inflammatory bowel disease in Austria.
Novacek G, Gröchenig HP, Haas T, Wenzl H, Steiner P, Koch R, Feichtenschlager T, Eckhardt G, Mayer A, Kirchgatterer A, Ludwiczek O, Platzer R, Papay P, Gartner J, Fuchssteiner H, Miehsler W, Peters PG, Reicht G, Vogelsang H, Dejaco C, Waldhör T; Austrian IBD Study Group (ATISG). Novacek G, et al. Among authors: papay p. Wien Klin Wochenschr. 2019 Mar;131(5-6):104-112. doi: 10.1007/s00508-019-1451-3. Epub 2019 Feb 4. Wien Klin Wochenschr. 2019. PMID: 30715607
Platelets Toll-like receptor-4 in Crohns disease.
Schmid W, Novacek G, Vogelsang H, Papay P, Primas C, Eser A, Panzer S. Schmid W, et al. Among authors: papay p. Eur J Clin Invest. 2017 Feb;47(2):109-116. doi: 10.1111/eci.12686. Epub 2016 Dec 29. Eur J Clin Invest. 2017. PMID: 27714784
The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease.
Harbord M, Annese V, Vavricka SR, Allez M, Barreiro-de Acosta M, Boberg KM, Burisch J, De Vos M, De Vries AM, Dick AD, Juillerat P, Karlsen TH, Koutroubakis I, Lakatos PL, Orchard T, Papay P, Raine T, Reinshagen M, Thaci D, Tilg H, Carbonnel F; European Crohn’s and Colitis Organisation. Harbord M, et al. Among authors: papay p. J Crohns Colitis. 2016 Mar;10(3):239-54. doi: 10.1093/ecco-jcc/jjv213. Epub 2015 Nov 27. J Crohns Colitis. 2016. PMID: 26614685 Free PMC article. No abstract available.
33 results